More on MRNA
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $136.62 |
|
|||
| Open | $137.91 | ||||
| 52 Wk High | $0.52 | ||||
| 52 Wk Low | $0.08 | ||||
| Day High | $149.73 | ||||
| Day Low | $135.01 | ||||
| P/E | N/A | ||||
| EPS | $-3.80 | ||||
| Volume | 15,137,861 | ||||
- Form 144 Moderna, Inc. Filed by: Mock James M
- Rothschild Redburn Downgrades Moderna (MRNA) to Sell
- Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
- Moderna to Present at Upcoming Conferences in September 2026
- BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast
- Argus Upgrades Moderna (MRNA) to Buy
- Moderna prices $2.6B convertible notes offering due 2032
- Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes
- FDA approves Moderna's updated 2026-2027 COVID-19 vaccines
- Moderna Receives U.S. FDA Approval for Updated 2026-2027 COVID-19 Vaccines
Entities mentioned with MRNA
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Options | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
